Efimosfermin alfa trials for Non-Alcoholic Fatty Liver Disease

All Efimosfermin alfa trials · All Non-Alcoholic Fatty Liver Disease trials

Phase breakdown

Recruiting trials studying Efimosfermin alfa for Non-Alcoholic Fatty Liver Disease

• A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
  NCT07221188 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 66 locations
• A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
  NCT07221227 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 91 locations
• A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
  NCT07358546 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 3 locations

Common questions

How many trials study Efimosfermin alfa for Non-Alcoholic Fatty Liver Disease?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.